Early Failure of Frontline Rituximab-containing Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma does not Predict Futility of Autologous Hematopoietic Cell Transplantation

The poor prognosis of diffuse large B-cell lymphoma (DLBCL) patients relapsing within 1-year of initial diagnosis after first-line rituximab-based chemoimmunotherapy has created controversy about the role of autologous transplantation (auto-HCT) in this setting. We compared auto-HCT outcomes of chem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hamadani, Mehdi, Hari, Parameswaran N., Zhang, Ying, Carreras, Jeanette, Akpek, Görgün, Aljurf, Mahmoud D., Ayala, Ernesto, Bachanova, Veronika, Chen, Andy I., Chen, Yi-Bin, Costa, Luciano J., Fenske, Timothy S., Freytes, César O., Ganguly, Siddhartha, Hertzberg, Mark S., Holmberg, Leona A., Inwards, David J., Kamble, Rammurti T., Kanfer, Edward J., Lazarus, Hillard M., Marks, David I., Nishihori, Taiga, Olsson, Richard, Reddy, Nishitha M., Rizzieri, David A., Savani, Bipin N., Solh, Melhem, Vose, Julie M., Wirk, Baldeep, Maloney, David G., Smith, Sonali M., Montoto, Silvia, Saber, Wael
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4194275/
https://ncbi.nlm.nih.gov/pubmed/25008330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.06.036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados